首页> 美国卫生研究院文献>The Journal of Experimental Medicine >Cytotoxic T lymphocytes reactive against a syngeneic murine tumor and their specific suppressor T cells are both elicited by in vitro allosensitization
【2h】

Cytotoxic T lymphocytes reactive against a syngeneic murine tumor and their specific suppressor T cells are both elicited by in vitro allosensitization

机译:对同种鼠肿瘤具有反应性的细胞毒性T淋巴细胞及其特异性抑制性T细胞均通过体外同种敏化作用诱发

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sensitization of C57BL/6 (B6, H-2b) splenocytes against normal BALB/c (H-2d) leukocytes (B6 a/BALB) in bulk MLC induced CTL reactive against the syngeneic (H-2b) nonimmunogenic lymphoma PIR-2, in addition to the CTL directed against the corresponding (H-2d) allotargets. However, MLC- derived lymphocytes did not directly exhibit anti-PIR-2 cytotoxicity in spite of the high anti-PIR-2 CTL frequency (up to 1/20) among them, as demonstrated by the limiting dilution culture (LDC) technique. The present study was undertaken to resolve this contradiction. We found that anti-PIR-2 cytotoxicity could be detected only when B6 a/BALB MLC- derived responding cells were plated in LDC at low numbers (less than 200) of cells/well. In contrast, increasing the number of the plated cells to 500-5,000 resulted in a gradual decrease in the percentage of wells cytotoxically reactive against PIR-2, whereas the percentage of wells exhibiting cytotoxicity against the allotargets remained unchanged (100%). This decrease of anti-PIR-2 cytotoxicity in LDC and the lack of anti-PIR-2 reactivity among MLC-derived lymphocytes were shown by mixing experiments to result from the activity of radioresistant Thy-1+, Lyt-2+, L3T4- suppressor cells, blocking the anti-PIR-2 cytotoxicity at the effector phase. The suppression was specific as indicated by the following observations: (a) freshly obtained B6 splenocytes, cultured unsensitized B6 splenocytes, mitogen- induced B6 lymphoblasts, B6 LAK cells, or B6 a/B6 MLC-derived lymphocytes were not suppressive; (b) anti-PIR-2 cytotoxicity elicited in B6 a/BALB LDC was suppressed only by lymphocytes derived from B6 a/BALB MLC and not from B6 a/C3H (H-2k) MLC; and (c) B6 a/BALB MLC- induced suppressor cells could be adsorbed on monolayers of BALB/c but not of C3H lymphoblasts. Since both syngeneic tumor and allogeneic target cells were lysed by the same clonal cell population but only the antisyngeneic activity was suppressed, we suggest that a single CTL can exhibit two cytotoxic activities that are differentially affected by the described suppressor cells. This mode of suppression may play a role in controlling autoimmune reactivity.
机译:M57诱导的C57BL / 6(B6,H-2b)脾细胞对正常BALB / c(H-2d)白细胞(B6 a / BALB)诱导的CTL对同基因(H-2b)非免疫原性淋巴瘤PIR-2有反应性,除了针对相应(H-2d)同素靶标的CTL外。然而,尽管其中有限的抗PIR-2 CTL频率(高达1/20)很高,但MLC衍生的淋巴细胞并未直接显示出抗PIR-2的细胞毒性,这是通过有限稀释培养(LDC)技术证明的。本研究是为了解决这一矛盾而进行的。我们发现只有将B6 a / BALB MLC衍生的应答细胞以低数量(少于200个)/孔接种在LDC中时,才能检测到抗PIR-2细胞毒性。相反,将接种细胞的数量增加至500-5,000导致针对PIR-2的细胞毒性反应的孔百分比逐渐降低,而对同种异体靶标表现出细胞毒性的孔百分比保持不变(100%)。通过混合实验表明,LDC中抗PIR-2细胞毒性的这种降低以及MLC来源的淋巴细胞中抗PIR-2反应性的缺乏是由放射抗性Thy-1 +,Lyt-2 +,L3T4-的活性导致的抑制细胞,在效应子阶段阻断抗PIR-2的细胞毒性。如以下观察结果所示,抑制作用是特异性的:(a)新鲜获得的B6脾细胞,未培养的B6脾细胞,有丝分裂原诱导的B6淋巴母细胞,B6 LAK细胞或B6 a / B6 MLC来源的淋巴细胞均未被抑制; (b)B6 a / BALB LDC引起的抗PIR-2细胞毒性仅被B6 a / BALB MLC来源的淋巴细胞抑制,而不受B6 a / C3H(H-2k)MLC来源的淋巴细胞抑制; (c)B6 a / BALB MLC诱导的抑制细胞可以吸附在BALB / c的单层上,但不能吸附在C3H淋巴母细胞上。由于同基因肿瘤细胞和同种异体目标细胞都被相同的克隆细胞群裂解,但是只有抗同基因活性被抑制,因此我们建议单个CTL可以表现出两种细胞毒性活性,这两种细胞均受到上述抑制细胞的影响。这种抑制模式可能在控制自身免疫反应性中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号